Vaswani, Pavan A. http://orcid.org/0000-0002-1826-6275
Morley, James F.
Jennings, Danna
Siderowf, Andrew http://orcid.org/0000-0002-1750-7698
Marek, Kenneth
Seibyl, John
Stern, Matthew
Russell, David
Sethi, Kapil
Frank, Samuel
Simuni, Tanya
Hauser, Robert
Ravina, Bernard
Richards, Irene
Liang, Grace
Adler, Charles
Saunders-Pullman, Rachel
Evatt, Marian L.
Lai, Eugene
Subramanian, Indu
Hogarth, Penelope
Chung, Kathryn
,
Funding for this research was provided by:
U.S. Department of Defense (W81XWH-06-067, W81XWH-06-067, W81XWH-06-067, W81XWH-06-067, W81XWH-06-067)
Article History
Received: 11 July 2022
Accepted: 22 May 2023
First Online: 29 June 2023
Competing interests
: The authors declare no competing interests. P.A.V. has received grant funding from the Edmond J. Safra Foundation and Michael J. Fox Foundation and has been a consultant to Abbvie. J.F.M. has received grant support from the Department of Defense. D.J. is an employee of Denali Therapeutics, Inc. A.S. has been a consultant to the following companies: Biogen, Prilenia Therapeutics, Wave, Praxis Therapeutics, Alector, Merck and Prevail. He has received grant funding from the Michael J. Fox Foundation and NINDS. K.M. has been a consultant for Invicro, Sanofi, Biohaven, Takeda, Alkahest, Denali, Astellas, Bial, Pfizer, GE Healthcare, Lilly, Calico, Biomx, Neuramedy, Roche and the Michael J Fox Foundation.